Key Highlights

● Revenue fell 27.6% to $76.4 million in the second quarter.

● Independent active earning coaches fell 48.7% to 11,700.

● Revenue per active earning coach rose 41.0% to $6,529.

● Cash and investments totaled $169.8 million with no debt.

Medifast, Inc. (NYSE:MED) is in the middle of a reset, and its coach network sits at the center of it. In the second quarter of 2026, the weight-management company reported that independent active earning coaches fell 48.7% to 11,700, yet revenue per active earning coach rose 41.0% to $6,529. That combination suggests a smaller but potentially more productive selling force. Management has framed the quarter as a step toward a return to profitability in the fourth quarter.

Latest Company Context

Medifast reported second-quarter 2026 revenue of $76.4 million, down 27.6% from $105.6 million a year earlier. The company posted a net loss of $3.1 million, or $0.28 per share, compared with net income of $2.5 million, or $0.22 per diluted share, in the prior-year period. Loss from operations was $4.3 million, or 5.7% of revenue. Gross margin was 69.9%, down from 72.6%, while selling, general and administrative expenses were $57.7 million, equal to 75.6% of revenue.

For the first six months, revenue was $152.4 million and the net loss was $5.2 million, or $0.47 per share. Cash, equivalents and investment securities totaled $169.8 million with no debt, compared with $167.3 million at December 31, 2025. Chief Executive Officer Nick Johnson said revenue held steady sequentially and pointed to coach productivity and leadership trends as supporting signs.

Key Business and Index Drivers

The first driver is the coach model. Fewer coaches generating more revenue each can be read two ways: a healthier core of active sellers, or a shrinking base that limits reach. The second driver is cost structure. The company launched its Catalyst program in the second quarter, with most execution expected in the third quarter. It targets savings from facility consolidation, AI-related efficiencies and other measures, and the company amended the lease at its Havre de Grace distribution facility to extend the term while reducing square footage.

The third driver is product. Medifast cited new offerings including the Trilivy brand, Reset Fuelings and the Medifast Metabolic Health Institute. Whether these broaden demand beyond the traditional coach channel is not yet evident in reported figures.

What Investors Should Watch

Guidance gives clear markers. For the third quarter of 2026, the company expects revenue of $60 million to $80 million and a loss per share of $0.15 to $0.65, excluding one-time Catalyst costs. For the full year, it guides to revenue of $270 million to $300 million and a loss per share of $0.25 to $1.75. The width of those ranges signals considerable uncertainty, and results could land at either end.

The third-quarter report will show how much Catalyst execution has been completed and whether one-time costs match expectations. Coach counts and revenue per coach will indicate whether the productivity gain persists. Gross margin, which slipped about 2.7 percentage points year over year, may also reveal pricing and mix pressures. Finally, the fourth-quarter profitability target is a management expectation rather than a confirmed outcome, and it depends on both revenue and cost delivery.

A Smaller, More Productive Coach Network

Medifast's latest quarter shows a business shrinking in volume while attempting to raise productivity and cut costs. The debt-free balance sheet, with $169.8 million in cash and investments, provides some room to carry out the Catalyst program, though the guidance ranges leave a wide spread of possible outcomes. Coach engagement, margin direction and the pace of cost savings could shape how the second half unfolds.